Target intelligence / Profile preview

Enterovirus 71 capsid 5-fold axis region (EV71 5-fold axis)

Target
EV71 5-fold axis
Molecular classification
Viral structural protein, Capsid protein, Viral attachment protein
01

Overview

The Enterovirus 71 (EV71) capsid 5-fold axis region is a prominent structural feature of the icosahedral viral shell, formed by the convergence of five VP1 capsid proteins (Plevka et al., 2012). This region is functionally significant as it contains the binding site for the P-selectin glycoprotein ligand-1 (PSGL-1) receptor, which facilitates viral entry into immune cells (Nishimura et al., 2009). The 5-fold vertex is characterized by a mesa structure that is a major target for potent neutralizing antibodies, such as D5 and 10D3, which block receptor attachment (Ye et al., 2016). Additionally, small molecules like suramin have been shown to bind specifically to the 5-fold axis, effectively neutralizing the virus by preventing its interaction with host cells (Wang et al., 2014). As EV71 is a primary causative agent of hand, foot, and mouth disease (HFMD) and can lead to severe neurological complications like encephalitis, this region is a critical target for both vaccine design and antiviral therapy (Baggen et al., 2018). The structural conservation of this region across different EV71 genotypes makes it an attractive site for developing broad-spectrum inhibitors.

Other names
EV71 5-fold vertexEnterovirus A71 capsid vertexVP1 5-fold symmetry axisEV71 mesa region
02

Mechanism of action

Inhibition of viral attachment to host receptors (e.g., PSGL-1) and prevention of viral uncoating by stabilizing the capsid structure or sterically hindering receptor access (Wang et al., 2014; Ye et al., 2016).

03

Biological functions

Viral attachmentReceptor bindingViral entryGenome uncoatingCapsid assembly
04

Disease associations

Hand, foot, and mouth disease (HFMD)EncephalitisAseptic meningitisAcute flaccid paralysisHerpangina
05

Safety considerations

Emergence of viral escape mutants due to capsid plasticityPotential for antibody-dependent enhancement (ADE)Systemic toxicity associated with polyanionic inhibitors like suraminNarrow therapeutic window for entry inhibitors
06

Interacting drugs

Suramin

5 more in the full profile.

07

Biomarkers

EV71 viral RNA (RT-PCR)VP1 antigen levelsNeutralizing antibody titers

Beyond the preview

Go deeper on Enterovirus 71 capsid 5-fold axis region (EV71 5-fold axis).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Enterovirus 71 capsid 5-fold axis region (EV71 5-fold axis).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call